Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. - Wikidata - awgldk - TriplyDB

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

http://www.wikidata.org/entity/Q44556007

about

Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.CD8+ DC, but Not CD8(-)DC, isolated from BCG-infected mice reduces pathological reactions induced by mycobacterial challenge infection.Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR.Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.The role of the thymus in tolerance.Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes The role of dendritic cells in tissue-specific autoimmunity.Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis.Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection.A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation.Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity.CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.Dendritic cells and tumor microenvironment: a dangerous liaison Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase Composite tissue allotransplantation immunology Indoleamine 2,3-dioxygenase and tumor-induced tolerance Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis IDO: a double-edged sword for T(H)1/T(H)2 regulation.T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance.A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells.Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.Indoleamine 2,3-dioxygenase: from catalyst to signaling function.Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments.Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.Comparative immunophenotyping of monocytes from symptomatic and asymptomatic atopic individuals.CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis.

P2860

Q21285076-3422ACD5-AE5A-42C7-AC5C-64FF43644966 Q28166057-6B40B05C-949C-4683-9726-62620E4EE866 Q28610462-38798A6A-5E3D-45EA-AB16-35B660244065 Q30931726-970C4F24-96C8-4BB1-AAD4-735A7F2DD911 Q33533344-44E15073-41ED-4EAD-B6EB-57CFBE6DEC95 Q33572246-A911DA85-5BA8-452E-975A-159FD665E749 Q33896713-7F987D78-A04E-49C3-914D-3553185F4D63 Q34103905-5F57CFBC-37D6-47A2-BD84-34BF870A1DCF Q34323684-B94F173A-2A85-4054-8513-AA1C743E45AB Q34422017-058DA003-0D44-4FAB-9BA2-8A5D6C188785 Q34655953-BE1E7B8A-62C4-4010-A30F-CB9436D29EE2 Q35048483-EDD5B1BD-7B64-48A0-8317-EB39C9D6C2ED Q35366959-93FDCBAB-685A-42CC-A546-C8998CB6672F Q35772650-1B8685A9-89A8-409F-93C7-B86B5F28C0BA Q35848222-B15FF9A2-CB9F-42E4-96BC-2E9EABBC47DB Q36088964-6D2BFF12-D11B-44AB-B9FC-750BF1719910 Q36399304-DAC62D90-42F2-4648-84BC-783892C10E98 Q36569018-77AE2C55-8544-435C-A920-BD82E7396173 Q36632492-DDE03C6D-2304-44DB-96FC-3794E048FAD9 Q36708274-C5C9A1B1-B528-402B-A008-830F1C07068D Q36809762-5EB8BAE0-E4E5-486A-906B-32323ADE4A3B Q36821053-A4757652-7D02-4961-8A8A-7CBA6E03445B Q36919773-AAF7103B-BC7B-45FD-88A0-1B27E5F461EB Q37081582-295547AD-0A37-4803-B6C5-54F1C33ED387 Q37281950-DC94580C-9390-43E3-AB8F-E4BAA5F8C218 Q37334065-2E21F4E4-5647-4AE4-8509-7DA77A3802DA Q37340475-5ED7E3D6-556E-49F9-871A-ADD50F171AEB Q37539824-BF57DB25-3FF3-4B38-A03C-3971BF1584DC Q37659828-1E691FA2-2963-497D-A444-1FDE494EC2AB Q37681196-6E56B8CB-7541-436F-A876-69C34D807A37 Q38031280-F091CDA7-8DE4-448F-853E-637E0F9FC7A9 Q38032201-9C57045B-5F26-4807-AEC0-961C7BD9CC59 Q38074155-FE8440C7-E31B-4E36-86EB-B9DB4E371BD9 Q41326662-364D32F5-63D7-4393-A269-5304705FA799 Q42484177-A5C95164-9F14-405E-BB3D-3877C927ACD2 Q42958588-79BBC6BF-E16F-4715-90A8-E07419E8BFCF Q45005644-E2642A13-FD49-4109-BDAA-A182701AB935 Q45092706-5653D77A-13B1-470F-9F6D-7A18F765967E Q45163458-BFECE88B-BE6D-43B3-9437-0E40789F51B5 Q45419013-62011E76-2444-4383-AA2B-B55234EA6EEE

P2860

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

http://www.wikidata.org/entity/Q44556007

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

@en

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

@nl

type

label

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

@en

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

@nl

prefLabel

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

@en

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

@nl

P1433

Q44556007-4B54BEA7-A522-46AD-8B48-C4F3E0749184

P1476

Q44556007-035CFD5A-A17A-4BA5-958C-48FB7A5EF3CE

P2093

Q44556007-1A2C8DBF-0E4C-4E11-9CEF-B6E819B5454A

Q44556007-269E61B9-27FF-4780-B00A-0112BE292DAC

Q44556007-5E5D0167-784B-4D0C-9E07-1B4B6FE2C8F3

Q44556007-83C5A518-8B93-4563-80D4-5121C4A2C8FC

Q44556007-D30E4EBE-885B-465F-A37F-C004A8F1F4AE

Q44556007-DC7B9596-832E-4991-85CB-D63025D3B2CC

Q44556007-DD7BCCA1-553E-426B-942E-C03C6581F07B

Q44556007-E86B1FCD-8E97-42D9-868A-F04A3920EBBA

P304

Q44556007-CE99ADE0-F962-4F59-8EF9-F24E03B4ADBD

P31

Q44556007-EED538F4-F236-4DF7-A3E5-4F6841647D8C

P356

Q44556007-8599011F-2ABA-411E-A5EE-0B3C820D4B45

P407

Q44556007-17F527BA-33A5-479D-955C-E61D7CD8D0C9

P433

Q44556007-36A0F628-5C1A-4934-96C7-2589374B3F52

P478

Q44556007-B727E279-B4AC-4A5E-9976-CB55F2F97264

P577

Q44556007-1F21B4A1-63D6-4010-8A62-5182373FF991

P5875

Q44556007-5882A0E7-EF5F-49AF-BC2F-B8E6D04F9EC7

P698

Q44556007-506D02F6-3EBD-4916-AA46-BE4E5C0F3589

P356

JIMMUNOL.171.5.2581

P1433

Journal of Immunology

P1476

Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.

@en

P2093

Alessandra Micheletti

http://www.w3.org/2001/XMLSchema#string

Carmine Vacca

http://www.w3.org/2001/XMLSchema#string

Ciriana Orabona

http://www.w3.org/2001/XMLSchema#string

Francesca Fallarino

http://www.w3.org/2001/XMLSchema#string

Maria C Fioretti

http://www.w3.org/2001/XMLSchema#string

Paolo Puccetti

http://www.w3.org/2001/XMLSchema#string

Roberta Bianchi

http://www.w3.org/2001/XMLSchema#string

Ursula Grohmann

http://www.w3.org/2001/XMLSchema#string

P304

2581-2587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.171.5.2581

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6243150

http://www.w3.org/2001/XMLSchema#string

P698

12928409

http://www.w3.org/2001/XMLSchema#string